# VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease

> **NCT06249165** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Duke University** · enrollment: 130 (actual)

## Conditions studied

- Atherosclerotic Cardiovascular Disease

## Interventions

- **DRUG:** Inclisiran

## Key facts

- **NCT ID:** NCT06249165
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-12-16
- **Primary completion:** 2026-12
- **Final completion:** 2027-02
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2025-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06249165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06249165, "VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06249165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*